ACORDA THERAPEUTICS INC's ticker is and the CUSIP is 00484MAA4. A total of 42 filers reported holding ACORDA THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $6,862,000 | +0.8% | 8,000,000 | 0.0% | 0.05% | -5.6% |
| Q1 2017 | $6,808,000 | +19923.5% | 8,000,000 | +17677.8% | 0.05% | – |
| Q4 2016 | $34,000 | -99.5% | 45,000 | -99.5% | 0.00% | -100.0% |
| Q3 2016 | $6,946,000 | -6.4% | 8,436,000 | 0.0% | 0.05% | -3.8% |
| Q2 2016 | $7,418,000 | -55.2% | 8,436,000 | -54.4% | 0.05% | -52.7% |
| Q1 2016 | $16,557,000 | -60.8% | 18,506,000 | -49.2% | 0.11% | -59.0% |
| Q4 2015 | $42,250,000 | +21.7% | 36,450,000 | -4.1% | 0.27% | +12.1% |
| Q3 2015 | $34,711,000 | -9.4% | 38,013,000 | +0.4% | 0.24% | +0.8% |
| Q2 2015 | $38,293,000 | +4.4% | 37,870,000 | +5.3% | 0.24% | +3.0% |
| Q1 2015 | $36,692,000 | +29.3% | 35,956,000 | +46.0% | 0.23% | +22.3% |
| Q4 2014 | $28,371,000 | +39.9% | 24,621,000 | +25.6% | 0.19% | +39.3% |
| Q3 2014 | $20,273,000 | – | 19,596,000 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opti Capital Management, LP | 7,500 | $6,276,000 | 2.99% |
| PFM Health Sciences, LP | 90,886,000 | $75,652,000 | 2.01% |
| Jabre Capital Partners S.A. | 1,750,000 | $1,474,000 | 1.68% |
| Partner Investment Management, L.P. | 1,108,000 | $922,000 | 1.15% |
| Telemetry Investments, L.L.C. | 2,000,000 | $1,655,000 | 1.06% |
| Worth Venture Partners, LLC | 1,562,000 | $1,312,000 | 0.99% |
| DLD Asset Management, LP | 12,000,000 | $10,028,000 | 0.69% |
| Castle Creek Arbitrage, LLC | 2,310,000 | $1,937,000 | 0.67% |
| CANYON CAPITAL ADVISORS LLC | 28,775,000 | $23,830,000 | 0.56% |
| SYMPHONY ASSET MANAGEMENT LLC | 2,000,000 | $1,665,000 | 0.49% |